Last updated on November 2018

Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia

Brief description of study

This clinical trial studies how well simplified patient care strategy works in decreasing early death in patients with acute promyelocytic leukemia. Implementing simplified acute promyelocytic leukemia guidelines along with support from acute promyelocytic leukemia experts may decrease deaths and improve survival.

Detailed Study Description


I. To evaluate if the proposed patient care strategy, that includes use of simplified guidelines along with acute promyelocytic leukemia (APL) expert support, decreases the one-month induction mortality rate from 30% to under 15%.


I. To assess the overall survival 1 year after accrual is completed. II. To assess incidence and severity of differentiation syndrome. III. To correlate outcomes with time to initiation of all-trans retinoic acid (ATRA) from diagnosis or suspicion of diagnosis.

IV. To compare outcomes between academic and community centers separately. V. To evaluate factors associated with outcome.


Patients receive standard of care treatment for APL. Patients? doctors regularly discuss with an APL expert to identify and mange treatment.

After diagnosis, patients are followed up for 1 year.

Clinical Study Identifier: NCT03253848

Find a site near you

Start Over

ECOG-ACRIN Cancer Research Group

Philadelphia, PA United States
  Connect »

Northwestern University

Chicago, IL United States
  Connect »

Mayo Clinic

Rochester, MN United States
  Connect »

Mayo Clinic in Florida

Jacksonville, FL United States
  Connect »

Boulder Community Hospital

Boulder, CO United States
  Connect »

Rose Medical Center

Denver, CO United States
  Connect »

Swedish Medical Center

Englewood, CO United States
  Connect »

McKee Medical Center

Loveland, CO United States
  Connect »